High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus.
Elevated levels of plasma fibronectin have been described in patients with active systemic lupus erythematosus (SLE). We demonstrated the presence of high levels of fibronectin fragments in the plasma of a patient during the terminal episode of active SLE. The potential consequences of circulating fibronectin fragments on clearance of immune complexes and microorganisms are discussed.